Importantly, we highlighted distinct TEC characteristics among various patients and cancer types, especially in terms of two representative statuses of TEC phenotype, proinflammatory and angiogenic, which could impact the treatment efficacy of AAT and immune checkpoint blockade (ICB). Here, SERPINA1 is linked to cancer.